Publications dans lesquelles il/elle collabore avec MARÍA LUISA CAÑADAS GARRE (21)
2021
-
Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis
Molecular Neurobiology, Vol. 58, Núm. 9, pp. 4716-4726
2020
-
Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis
Pathology Research and Practice, Vol. 216, Núm. 4
-
Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma
Surgical Oncology, Vol. 35, pp. 388-398
2019
-
Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients
Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 63-70
-
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients
Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 164-177
2018
-
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer
Pathology Research and Practice, Vol. 214, Núm. 1, pp. 44-52
-
Pharmacogenetic biomarkers of response in Crohn's disease
Pharmacogenomics Journal, Vol. 18, Núm. 1, pp. 1-13
2017
-
ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis
Surgical Oncology, Vol. 26, Núm. 4, pp. 473-482
-
Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
Mutation Research - Reviews in Mutation Research, Vol. 771, pp. 32-58
-
Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer
Pharmacogenetics and Genomics, Vol. 27, Núm. 12, pp. 438-444
-
Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer
Surgical Oncology, Vol. 26, Núm. 3, pp. 278-285
2016
-
ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients
Pharmacological Research, Vol. 108, pp. 111-118
-
Gene polymorphisms as predictors of response to biological therapies in psoriasis patients
Pharmacological Research, Vol. 113, pp. 71-80
-
Liquid biopsy in early stage lung cancer
Translational Lung Cancer Research, Vol. 5, Núm. 5, pp. 517-524
-
Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients
Pharmacological Research, Vol. 111, pp. 877-884
2015
-
De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer
Pharmacogenomics, Vol. 16, Núm. 12, pp. 1411-1426
-
MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer
Pharmacological Research, Vol. 102, pp. 90-106
-
MET: A new promising biomarker in non-small-cell lung carcinoma
Pharmacogenomics, Vol. 16, Núm. 6, pp. 631-647
-
Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer
Breast Cancer Research and Treatment, Vol. 153, Núm. 3, pp. 493-505
-
PTEN and PI3K/AKT in non-small-cell lung cancer
Pharmacogenomics, Vol. 16, Núm. 16, pp. 1843-1862